发明名称 O-SUBSTITUTED HYDROXYARYL DERIVATIVES
摘要 Drugs having inhibitory activity against NF-&kgr;B activation, containing as the active ingredient substances selected from the group consisting of compounds represented by the general formula (I), pharmacologically acceptable salts thereof, and hydrates and solvates of both:wherein X is a connecting group whose main chain has two to five atoms and which may be substituted;A is optionally substituted acyl (exclusive of unsubstituted acetyl and unsubstituted acryloyl) or optionally substituted C-alkyl, or alternatively A and X may be united to form a ring structure which may be substituted;E is optionally substituted aryl or optionally substituted heteroaryl; andZ is arene which may have a substituent in addition to the groups represented by the general formulae: -O-A (wherein A is as defined above) and -X-E (wherein X and E are each as defined above) or heteroarene which may have a substituent in addition to the groups represented by the general formulae: -O-A (wherein A is as defined above) and -X-E (wherein X and E are each as defined above).
申请公布号 EA009051(B1) 申请公布日期 2007.10.26
申请号 EA20040001614 申请日期 2003.06.05
申请人 INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. 发明人 MUTO SUSUMU;ITAI AKIKO
分类号 A61K31/167;A61K31/18;A61K31/222;A61K31/27;A61K31/4035;A61K31/4406;A61K31/4409;A61K31/445;A61K31/4453;A61K31/495;A61K31/536;A61K31/5377;A61K31/55;A61K31/609;A61K31/625;A61K31/661;A61K31/7034;A61K38/00;A61P29/00;A61P37/06;A61P43/00;C07D209/48;C07D211/62;C07D213/79;C07D213/803;C07D265/22;C07D265/26;C07D267/00;C07D269/00;C07D273/00;C07D277/46;C07D295/18;C07D295/185;C07D295/20;C07D295/205;C07D309/10;C07D317/60;C07D317/68;C07K5/06;C07K5/065;C07K5/068;C07K5/072 主分类号 A61K31/167
代理机构 代理人
主权项
地址